TSVT

2seventy bio, Inc.

4.20 USD
+0.11 (+2.69%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

2seventy bio, Inc. stock is down -13.76% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
30 Apr 14:10 20 Dec, 2024 2.50 CALL 125 127

About 2seventy bio, Inc.

2seventy bio, Inc. focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.